Johne’s Disease Diagnostics Market Size was valued at USD 652.6 million in 2023 and is expected to reach USD 1076.6 million by 2032, growing at a CAGR of 5.7% over the forecast period 2024-2032.
This report provides an overview of the Johne’s Disease Diagnostics market, detailing the key insights and trends, discusses the incidence and prevalence of Johne’s disease in the target audience characterized across the key regions, and provides projections. It also surveys the technology-wise rate of diagnostic adoption (ELISA, PCR, culture-based tests) and the growth of diagnostic kits & services. This report summarizes global trends in testing for Johne's Disease and the associated infrastructure for diagnosing the disease. It also looks at the disease's costs to the health system, covering public, private, and research spending. The report also provides insight into the evolving regulatory and compliance structure and highlights the approval of oat-based feed standards for livestock health and its effects on diagnostic practices globally.
The Johne’s Disease Diagnostics Market is driven by increasing awareness of Mycobacterium avium subspecies paratuberculosis (MAP) infections, which cause significant economic losses in the livestock industry. In 2023, the U.S. accounted for about 31% of the total market share in the world, with strong uptake of advanced diagnostic techniques like PCR and ELISA tests. Market growth has also been fuelled by government initiatives promoting sustainable farming and animal welfare, as producers increasingly adopt reliable methods for managing infected livestock. Johne’s disease is a chronic infection caused by a bacterium that typically affects cattle, sheep, and goats and is an international problem for the health of livestock. The disease leads to decreased milk production and weight loss which affects their productivity, highlighting the need for early and accurate diagnosis.
Drivers
Advancements in diagnostic technologies like PCR and ELISA offer improved accuracy, sensitivity, and speed for early detection. This enhances disease control measures, reducing economic losses in the livestock industry.
Advancements in diagnostic technologies have significantly enhanced the detection and management of Johne's disease in livestock. Recent innovations include the development of molecular-based testing kits such as 'Johne-Find' and 'Johne-FindPRO' by the National Agriculture and Food Research Organization (NARO) and Nippon Gene Co., Ltd. Introduced in December 2023, 'Johne-Find' enables detection of infected cattle more than six months earlier than traditional antibody ELISA tests, while 'Johne-FindPRO' offers high specificity for confirmatory testing. In September 2023, diagnostics company MI:RNA unveiled an AI-powered testing method utilizing microRNA biomarkers, achieving 73% sensitivity and 71% specificity in identifying Johne’s disease. This approach holds promise for early-stage infection detection and outcome prediction.
Polymerase Chain Reaction (PCR) technology has also seen widespread adoption due to its high accuracy and sensitivity. In 2023, the PCR segment dominated the Johne’s disease diagnostics market, accounting for 45.3% of the market share. These advancements contribute to more effective disease control strategies, reducing economic losses in the livestock industry. For instance, Johne's disease leads to decreased milk production and weight loss in cattle, resulting in substantial financial impacts. Early detection through improved diagnostics enables timely intervention, mitigating these losses and enhancing overall herd health.
Restraint
High costs of advanced diagnostic tests limit adoption, especially among small-scale farmers. Financial constraints in developing regions further hinder market expansion.
Some of the most significant obstacles to widespread approval by producers, especially small-scale livestock producers, are the high prices of diagnostic tests for Johne’s illness. To illustrate, a single ELISA test in the United States costs around $6.50 per sample, and PCR upwards of $50 per sample. UK pricing for serum ELISA tests, subject to volume discounts, is between £5.20 and £5.85 per sample. Costs can mount quickly, especially for farmers with large herds to manage, and regular testing can be prohibitively expensive. Moreover, developed regions have fewer LTD units as compared to new ones the poor availability of cheap diagnostic facilities in these backgrounds emerges as a challenge in these areas, limiting the management of diseases and control efforts. In conclusion, tackling the cost barriers outlined here is crucial to increase the uptake of diagnostic testing and decrease the economic burden of Johne’s disease on the global livestock industry.
Opportunity
Growth in the livestock industry and rising disease awareness in emerging economies drive demand for effective diagnostics. Increased veterinary investments further support market expansion.
The growing livestock industry is an opportunity for Johne’s Disease Diagnostics Market especially in developing countries. With this increase comes a notable trend for developing accrete regions to focus more on animal husbandry. With growing larger livestock populations comes an increased risk of some pathogens, such as Johne's disease, a contagious infection that impacts cattle, sheep, and goats. For example, In the United States, approximately 68% of dairy herds have at least one cow that tests positive for Johne's disease, leading to economic losses due to reduced milk production and early culling. Although detailed data on infections in emerging economies is sparse, the international nature of livestock trade and movements indicates that the incidence of these infections could increase.
Particularly when it comes to Johne's disease, this challenge requires utilizing state-of-the-art diagnostic tools to identify and best manage the disease. Growing awareness among farmers and veterinarians about the economic impact of livestock diseases in these regions is creating demand for accurate diagnostic solutions. In addition, governmental campaigns on better animal health care and productivity, including India’s Rashtriya Gokul Mission and National Livestock Mission will provide further momentum towards the adoption of diagnostic technologies. The flourishing growth of the livestock segment in developing economies and increasing awareness levels along with supportive policies create a favorable climate for the growth of Johne’s Disease Diagnostics Market.
Challenge
Genetic diversity of Mycobacterium avium subsp. paratuberculosis complicates diagnostic development. Different strains require tailored approaches, making universal detection difficult.
Mycobacterium avium subspecies paratuberculosis (MAP) is the etiological agent of Johne's disease whose high genetic diversity impacts the development of diagnostic tests. MAP strains can be broadly categorized into two major groups depending on their type: Type S (sheep-type) and C (cattle-type). These groups show significant genetic and phenotypic differences such as these differences in growth rates, colony morphology, and pathogenicity. For example, Type S lineages tend to grow more slowly and do not necessarily flourish on media formulations that allow Type C strains to thrive. Such diversity complicates the establishment of universal diagnostic tests, since assays that are optimal for one strain type may have poor performance for others. Therefore, early detection and surveillance for Johne's disease in various animal species is difficult, and different diagnostic techniques are required depending on the MAP strain. Knowledge of the genetic and phenotypic differences between MAP strains is important for the design of effective diagnostics and control measures.
By Animal Type
In 2023, the Johne’s Disease Diagnostics Market was led by the cattle segment as it represented over 86% of the revenue share. This is largely due to the high incidence of Johne’s disease in dairy and beef cattle globally. The herds harboring Mycobacterium avium subspecies paratuberculosis (MAP) the organism responsible for Johne’s disease which is responsible for a large number of economic losses, especially losses related to milk production, weight loss, and culling of infected animals with the USDA reporting nearly 68% average infection rate, for the U.S. dairy herd of MAP-infection through population-level estimates. The disease’s effect on productivity has made early and accurate diagnostics a global priority for cattle farmers.
Government initiatives have been key in driving diagnostic solution adoption in this segment. For instance, the USDA’s Voluntary Bovine Johne’s Disease Control Program encourages routine testing and biosecurity measures to reduce infection rates. For example, the Irish Johne's Control Programme (IJCP) strives to enhance herd health by encouraging regular diagnostic and management practices. These programs are familiarizing livestock owners with the importance of detection and prevention, and also prevention. The cattle segment has also benefited from technological advancements. Recent diagnostic strategies including enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) testing have high sensitivity and specificity and can detect human infection at an early stage when interventions are most valuable. Simultaneous diagnosis of multiple pathogens through multiplexed diagnostic tests is also growing in popularity among cattle farmers looking for holistic herd health solutions.
By Test Type
PCR (Polymerase Chain Reaction) segment has dominated the Johne's Disease Diagnostics Market in 2023. It contributed to over 37% revenue share for Johne's Code Diagnostics market, in 2023. This is due to PCR being able to identify MAP DNA in fecal samples as it is significantly more accurate and has greater sensitivity than conventional methods such as ELISA or AGID (Agar Gel Immunodiffusion). They can detect low levels of DNA from the bacterium, which makes them very useful for detecting the disease if clinical signs have not yet appeared. The fast and reliable results produced by PCR are one of the major factors behind its dominance. Unlike serological tests based on antibody responses, which might take time to get to a level that could be measured, PCR directly detects the presence of the MAP bacteria. This is especially useful for herd disease spread control. In addition, rapid developments in molecular diagnostics have facilitated the availability and affordability of PCR in veterinary diagnostics.
Another driver for the adoption of PCR-based diagnostics has been various government initiatives. In many countries, like Australia and Canada, Johne’s disease is notifiable and herds are regularly screened, which ensures that farmers are using sensitive diagnostic tools such as PCR. Additionally, molecular testing has been promoted through the USDA's Voluntary Bovine Johne's Disease Control Program. These economic advantages also bolster PCR in the market. PCR shows the infected animal before they are at the symptomatic stage, which enables the farmer to isolate their livestock and stop the cycle of infection that leads to productivity losses from late-stage infections. Additionally, multiplex PCR assays that can detect several pathogens at once are becoming more desirable to livestock producers looking for all-in-one diagnostic solutions.
By End-use
In 2023, veterinary hospitals & clinics dominated the johne's disease diagnostics market, commanding over 52% of the revenue share. This dominance can be associated with the fact that they offer expert-administered advanced diagnostic services such as ELISA and PCR testing. Veterinary practices have the specialized infrastructure to correctly diagnose and address Johne's disease in a timely fashion. Accessibility is one of the major drivers of growth in this segment. As primary contact points for livestock owners wanting their animals assessed for health Veterinarians care in hospitals and clinics Disease control strategies have made these facilities a necessary addition, as only trained veterinarians have the skills to interpret test results and advise on proper management practices.
The demand for diagnostic services at veterinary hospitals and clinics has been further supported by government initiatives. Because Johne’s disease is also a herd-specific and long-term chronic disease, no one program will work for all herds, so programs promoting testing routinely of Johne’s disease often farm with a network of veterinarians so they can reach farmers at the right time. Example programs include initiatives like the USDA’s Voluntary Bovine Johne’s Disease Control Program, which incentivizes flock owners to seek professional veterinary services for disease control. Such hospitals also have an importance role in educating farmers about biosecurity protocols to avoid contagious diseases spread among herds. They also help with follow-up testing and monitoring, which is critical for herd health over the long term.
In 2023, North America led Johne’s Disease Diagnostics Market with a 33% market share due to the strong veterinary infrastructure, high level of awareness among livestock owners, and good government support for disease control programs. The U.S., which has a sizable share of global market share, has been a leader because of its sophisticated diagnostic technologies and broader acceptance of programs such as the USDA's Voluntary Bovine Johne's Disease Control Program. The programs encourage ongoing testing via methods like ELISA and PCR.
The Asia Pacific was the fastest growing region with a high CAGR during the forecast period 2024–2032 owing to rising meat consumption coupled with increasing prevalence rates in China and India. With increasing livestock herds in the region, demand for advanced diagnostics has increased as farmers seek solutions to combat the productivity losses caused by Johne’s disease. The initiatives taken by the government in Asia Pacific, have also contributed in a significant manner toward the growth of the market. India, fortunately, has initiated national programs to deal with animal health issues via screening and vaccination on a long-term basis to control zoonotic diseases. Moreover, the rise in investments in veterinary infrastructure across the developing economies has improved access to diagnostic services.
Zoetis Inc. (Vetscan Imagyst, Parachek)
IDEXX Laboratories, Inc. (Johne's ELISA Test, Johne's PCR Test)
Thermo Fisher Scientific Inc. (VetMAX MAP Real-Time PCR Kit, ELISA Test Kits)
PBD Biotech Ltd. (Actiphage Rapid, Actiphage Confirmatory)
IDvet (ID Screen Paratuberculosis Indirect Screening Test, ID Screen Paratuberculosis Indirect Confirmation Test)
VMRD, Inc. (Johne's Antibody Test Kit, Bovine Paratuberculosis ELISA)
bioMérieux SA (VIDAS Johne's Disease Assay, ELISA Kits)
INDICAL BIOSCIENCE GmbH (VetMAX MAP Real-Time PCR Kit, PathoProof Mastitis PCR Assay)
MV Diagnostics (Sure Farm Ltd) (ParaCheck Faecal Test, ParaCheck Blood Test)
Tetracore, Inc. (Johne's Disease Antibody Test Kit, Paratuberculosis PCR Test)
HiMedia Laboratories (HiPer Johne's Detection Kit, ELISA Test Kits)
Promega Corporation (Maxwell RSC Viral Total Nucleic Acid Purification Kit, GoTaq Probe qPCR Master Mix)
Pictor Diagnostics (Multiplexed ELISA Test, PictArray Technology)
Epitopix (Johne's Disease Vaccine, Diagnostic Test Kits)
Merck Animal Health (Paratuberculosis ELISA Kit, Johne's Disease PCR Test)
Randox Laboratories (Paratuberculosis ELISA Test, PCR Assays)
QIAGEN (QIAamp DNA Mini Kit, QuantiFERON)
Neogen Corporation (Para-D-Tec, Johne's Disease PCR Kit)
Bio-Rad Laboratories (ELISA Test Kits, PCR Detection Kits)
Agrolabo S.p.A. (Paratuberculosis Diagnostic Kits, ELISA Test Kits)
IDEXX Laboratories launched a PCR-based diagnostic test for early-stage MAP infections in September 2024.
In October 2024, automated diagnostic devices with the intent to make test trying easier and quicker were introduced by Thermo Fisher Scientific.
In November 2024, The USDA expanded funding for nationwide Johne’s disease eradication programs targeting rural farming communities across multiple states.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 652.6 Million |
| Market Size by 2032 | USD 1076.6 Million |
| CAGR | CAGR of 5.47% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Animal Type (Cattle, Sheep, Goat) • By Test Type (ELISA, AGID, PCR) • By End-use (Veterinary Hospitals & Clinics, Others |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Zoetis Inc., IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., PBD Biotech Ltd., IDvet, VMRD, Inc., bioMérieux SA, INDICAL BIOSCIENCE GmbH, MV Diagnostics (Sure Farm Ltd), Tetracore, Inc., HiMedia Laboratories, Promega Corporation, Pictor Diagnostics, Epitopix, Merck Animal Health, Randox Laboratories, QIAGEN, Neogen Corporation, Bio-Rad Laboratories, Agrolabo S.p.A. |
Ans. The projected market size for the Johne’s Disease Diagnostics Market is USD 1076.6 Billion by 2032.
Ans. The CAGR of the Johne’s Disease Diagnostics Market is 5.74% During the forecast period of 2024-2032.
Ans: The North American region dominated the Johne’s Disease Diagnostics Market in 2023.
Ans: High costs of advanced diagnostic tests limit adoption, especially among small-scale farmers. Financial constraints in developing regions further hinder market expansion.
Ans: The Veterinary Hospitals & Clinics segment dominated the Johne’s Disease Diagnostics Market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Diagnostic Adoption Rates, By Technology (2023)
5.2 Market Volume & Growth in Diagnostic Kits (2020-2032)
5.3 Veterinary Testing Trends & Laboratory Infrastructure
5.4 Healthcare Expenditure & Funding (2023)
5.5 Regulatory & Compliance Landscape (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Johne’s Disease Diagnostics Market Segmentation, By Animal Type
7.1 Chapter Overview
7.2 Cattle
7.2.1 Cattle Market Trends Analysis (2020-2032)
7.2.2 Cattle Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 Sheep
7.3.1 Sheep Market Trends Analysis (2020-2032)
7.3.2 Sheep Market Size Estimates and Forecasts to 2032 (USD Million)
7.4 Goat
7.4.1 Goat Market Trends Analysis (2020-2032)
7.4.2 Goat Market Size Estimates and Forecasts to 2032 (USD Million)
8. Johne’s Disease Diagnostics Market Segmentation, By Test Type
8.1 Chapter Overview
8.2 ELISA
8.2.1 ELISA Market Trends Analysis (2020-2032)
8.2.2 ELISA Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 AGID
8.3.1 AGID Market Trends Analysis (2020-2032)
8.3.2 AGID Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 PCR
8.4.1 PCR Market Trends Analysis (2020-2032)
8.4.2 PCR Market Size Estimates and Forecasts to 2032 (USD Million)
9. Johne’s Disease Diagnostics Market Segmentation, By End Use
9.1 Chapter Overview
9.2 Veterinary Hospitals & Clinics
9.2.1 Veterinary Hospitals & Clinics Market Trends Analysis (2020-2032)
9.2.2 Veterinary Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Million)
9.3 Others
9.3.1 Others Market Trends Analysis (2020-2032)
9.3.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Johne’s Disease Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.2.3 North America Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.2.4 North America Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.2.5 North America Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.2.6 USA
10.2.6.1 USA Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.2.6.2 USA Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.2.6.3 USA Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.2.7 Canada
10.2.7.1 Canada Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.2.7.2 Canada Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.2.7.3 Canada Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.2.8 Mexico
10.2.8.1 Mexico Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.2.8.2 Mexico Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.2.8.3 Mexico Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.1.3 Eastern Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.1.4 Eastern Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.1.5 Eastern Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.1.6 Poland
10.3.1.6.1 Poland Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.1.6.2 Poland Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.1.6.3 Poland Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.1.7 Romania
10.3.1.7.1 Romania Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.1.7.2 Romania Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.1.7.3 Romania Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.1.8.2 Hungary Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.1.8.3 Hungary Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.1.9.2 Turkey Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.1.9.3 Turkey Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.1.10.2 Rest of Eastern Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.1.10.3 Rest of Eastern Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.2.3 Western Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.2.4 Western Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.2.5 Western Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.2.6 Germany
10.3.2.6.1 Germany Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.2.6.2 Germany Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.2.6.3 Germany Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.2.7 France
10.3.2.7.1 France Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.2.7.2 France Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.2.7.3 France Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.2.8 UK
10.3.2.8.1 UK Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.2.8.2 UK Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.2.8.3 UK Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.2.9 Italy
10.3.2.9.1 Italy Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.2.9.2 Italy Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.2.9.3 Italy Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.2.10 Spain
10.3.2.10.1 Spain Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.2.10.2 Spain Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.2.10.3 Spain Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.2.11.2 Netherlands Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.2.11.3 Netherlands Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.2.12.2 Switzerland Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.2.12.3 Switzerland Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.2.13 Austria
10.3.2.13.1 Austria Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.2.13.2 Austria Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.2.13.3 Austria Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.3.2.14.2 Rest of Western Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.3.2.14.3 Rest of Western Europe Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Johne’s Disease Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.4.3 Asia Pacific Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.4.4 Asia Pacific Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.4.5 Asia Pacific Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.4.6 China
10.4.6.1 China Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.4.6.2 China Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.4.6.3 China Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.4.7 India
10.4.7.1 India Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.4.7.2 India Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.4.7.3 India Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.4.8 Japan
10.4.8.1 Japan Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.4.8.2 Japan Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.4.8.3 Japan Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.4.9 South Korea
10.4.9.1 South Korea Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.4.9.2 South Korea Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.4.9.3 South Korea Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.4.10 Vietnam
10.4.10.1 Vietnam Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.4.10.2 Vietnam Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.4.10.3 Vietnam Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.4.11 Singapore
10.4.11.1 Singapore Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.4.11.2 Singapore Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.4.11.3 Singapore Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.4.12 Australia
10.4.12.1 Australia Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.4.12.2 Australia Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.4.12.3 Australia Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.4.13.2 Rest of Asia Pacific Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.4.13.3 Rest of Asia Pacific Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Johne’s Disease Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.1.3 Middle East Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.5.1.4 Middle East Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.5.1.5 Middle East Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.5.1.6 UAE
10.5.1.6.1 UAE Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.5.1.6.2 UAE Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.5.1.6.3 UAE Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.5.1.7.2 Egypt Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.5.1.7.3 Egypt Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.5.1.8.2 Saudi Arabia Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.5.1.8.3 Saudi Arabia Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.5.1.9.2 Qatar Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.5.1.9.3 Qatar Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.5.1.10.2 Rest of Middle East Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.5.1.10.3 Rest of Middle East Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Johne’s Disease Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.2.3 Africa Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.5.2.4 Africa Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.5.2.5 Africa Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.5.2.6.2 South Africa Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.5.2.6.3 South Africa Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.5.2.7.2 Nigeria Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.5.2.7.3 Nigeria Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.5.2.8.2 Rest of Africa Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.5.2.8.3 Rest of Africa Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Johne’s Disease Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.6.3 Latin America Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.6.4 Latin America Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.6.5 Latin America Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.6.6 Brazil
10.6.6.1 Brazil Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.6.6.2 Brazil Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.6.6.3 Brazil Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.6.7 Argentina
10.6.7.1 Argentina Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.6.7.2 Argentina Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.6.7.3 Argentina Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.6.8 Colombia
10.6.8.1 Colombia Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.6.8.2 Colombia Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.6.8.3 Colombia Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Johne’s Disease Diagnostics Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Million)
10.6.9.2 Rest of Latin America Johne’s Disease Diagnostics Market Estimates and Forecasts, By Test Type (2020-2032) (USD Million)
10.6.9.3 Rest of Latin America Johne’s Disease Diagnostics Market Estimates and Forecasts, By End Use (2020-2032) (USD Million)
11. Company Profiles
11.1 Zoetis Inc.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 IDEXX Laboratories, Inc.
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Thermo Fisher Scientific Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 PBD Biotech Ltd.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 IDvet
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 VMRD, Inc.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 bioMérieux SA
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 INDICAL BIOSCIENCE GmbH
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 MV Diagnostics (Sure Farm Ltd)
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Tetracore, Inc.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Animal Type
Cattle
Sheep
Goat
By Test Type
ELISA
AGID
PCR
By End-use
Veterinary Hospitals & Clinics
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
Women's Health Diagnostics Market valued at USD 25.30 billion in 2023, projected to reach USD 49.00 billion by 2032, growing at a 7.64% CAGR from 2024 to 2032.
The Clinical Workflow Solutions Market Size was valued at USD 11.07 billion in 2023 and will reach $32.71 billion by 2032, growing at a CAGR of 12.81% over the forecast period of 2024-2032.
The Dry Eye Syndrome Treatment Market size was valued at USD 5.86 billion in 2023 and is expected to grow at a CAGR of 6.32% to reach USD 10.17 billion by 2032
The Tumor Profiling Market size was valued at USD 10.5 Billion in 2023 and is expected to reach USD 24.8 Billion by 2032, growing at a 10.04% CAGR.
The mRNA Technology Market was valued at USD 35.67 billion in 2023 and is expected to reach USD 76.45 billion by 2032 with a growing CAGR of 8.88%.
The GLP-1 Receptor Agonist Market size was USD 43.79 billion in 2023 and is projected to grow to USD 193.56 billion by 2032, with a CAGR of 17.61%.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
